Skip to main content

Zopiclone Facts

Depressant; Hypnotic; Sedative; Cyclopyrrolone; GABA-A receptor positive allosteric modulator

Description

Zopiclone is a synthetic hypnotic of the cyclopyrrolone class. It amplifies GABA — the brain's primary calming signal — producing rapid, heavy sedation.

Subjective effects include heavy drowsiness, muscle relaxation, anxiety relief, and memory gaps for events after dosing. The experience is defined by a rapid, weighted descent into sleep and a persistent bitter-metallic taste beginning within minutes — unique among sedatives.[1]

Zopiclone produces physical dependence with regular use, though its dependence potential is lower than benzodiazepines;[2] deaths from zopiclone alone are rare.[3] The primary danger is combination: adding alcohol, opioids, or benzodiazepines transforms a manageable single-drug overdose into a potentially fatal one.[3]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 2 mgLight3.5 – 5 mgCommon5 – 7.5 mgStrong7.5 – 15 mgHeavy15+ mg

Starts in 10 – 30 minLasts 3.5 – 9 hoursAfter-effects 2 – 10 hours

Body and dependence

Acute toxicity
Low
Chronic toxicity
Moderate
Physical dependence
Moderate
Psychological dependence
Moderate
Withdrawal
Moderate
Compulsive redosing
Low

Tolerance

Builds
Slow
Fully resets after
10.5 days
Carries over to
benzodiazepines; zolpidem; zaleplon

Effectslikely at a common dose

Perception
none likely · 7 possible, including Visual acuity suppression, Spatial disorientation, Vestibular distortion
Body
Physical fatigue; Motor control impairment; Muscle relaxation; Sedation; +7 possible, including Dizziness, Insomnia, Headache
Thinking
Cognitive impairment; Focus suppression; +13 possible, including Analysis suppression, Decision impairment, Information processing suppression
Feeling
Anxiety suppression; +4 possible, including Anxiety
Self
none likely · 4 possible, including Communication suppression, Craving
Time
none likely · 1 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Breastfeeding; Concurrent CNS depressant use
Relative
Respiratory insufficiency; Myasthenia gravis; History of substance use disorder; Severe hepatic impairment; Pregnancy; Elderly (>70 years); Driving or machinery operation within 10 hours

Combinations60 recorded

Lethal (1)
Opioids
Dangerous (21)
Alpha-2 adrenergic receptor antagonist; Antipsychotics; Atypical antipsychotics; Benzodiazepines; Buprenorphine, Kratom; Cannabis, THC; Clonidine, Guanfacine; Gabapentin, Pregabalin; GHB, Baclofen; GHB, GBL; Local anesthetics; Naltrexone; SNRIs; Stimulants; Synthetic cannabinoids; Ibogaine; Ketamine, DXM, PCP; MAOIs; NSAIDs; Poppers (Alkyl nitrites); Poppers, Nitrates
Caution (26)
See full page: psychedex.org/substances/zopiclone
Not graded (12)
Not listed never means safe.

Seek help immediately if

  • Extreme drowsiness — can't stay awake or be roused
  • Confusion, slurred speech, severe loss of coordination
  • Slow, shallow, or irregular breathing
  • Unconsciousness / unresponsive; limp, floppy body
  • Blue lips or fingertips
  • Vomiting while sedated (choking / aspiration risk)
  • Cold, clammy skin; weak pulse

What to do

  1. Try to wake them — shout, firm sternal rub
  2. If unresponsive or breathing is impaired, call emergency services
  3. Place them in the recovery position — critical, they can choke on vomit
  4. Monitor breathing continuously; be ready to give rescue breaths / CPR
  5. Never leave them alone to "sleep it off"
  6. Do not give other drugs, stimulants, or more depressants

Most depressant overdoses resolve with airway protection, breathing support, and monitoring. The danger is respiratory depression and choking on vomit — sharply worse when combined with opioids or alcohol. GHB/GBL overdoses often involve sudden deep unconsciousness and may self-resolve, but airway protection is essential.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Caille G, du Souich P, Spenard J, Lacasse Y, Vezina M (1984) Pharmacokinetic and clinical parameters of zopiclone and trimipramine when administered simultaneously to volunteers — Biopharmaceutics & Drug Disposition PMID:6743780
  2. [2]
    ^Goa KL, Heel RC (1986) Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic — Drugs PMID:2874974
  3. [3]
    ^abGunja N (2013) The Clinical and Forensic Toxicology of Z-drugs — Journal of Medical Toxicology doi:10.1007/s13181-013-0292-0
Print version
Report an issue